Reporting owner · CIK 0001622058

Troendle August J.

Visual SEC Form 4 history across 1 companies, 12 transactions and 4 filings.

PRES, CEOPresident & CEOMedpace Holdings, Inc.
Open-market mix
Latest filingAug 31, 2026, 08:11 PM
Filings4Form 4 records
Buying$00 purchases
Selling$29.6M5 sales
Net value−$29.6MBuys minus sells
Companies12 securities
Most recentAug 27, 2026sale

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-5Mar 255Aug 26

Net value flow

Buys minus sells

Mar 25
$0
Aug 26
−$29.6M

Transaction texture

Ownership and ticket size

Average P/S size$5.9M
Median P/S size$2.5M
Direct12
Indirect0
Aug 27, 2026sale

Filing-only signals

Deterministic matches in this insider's history

Cluster Sellingpattern5Derivative Transactionfiling-context4Direct Ownershipfiling-context12Large Holdings Increaseholdings2Large Salesize3Repeat Sellerpattern4

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at Medpace Holdings, Inc. on Aug 27, 2026 valued at $403,176.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at Medpace Holdings, Inc. on Aug 27, 2026 valued at $403,176.

Review SEC filing

Associated companies

Visual map of known reporting history

MEDPMedpace Holdings, Inc.12 transactions · latest Aug 31, 2026, 08:11 PM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
MEDPTroendle August J.
PRESCEO
sale650-$40.3MS
Cluster Selling Direct Ownership Repeat Seller
0.0%08/3108/27
MEDPTroendle August J.
PRESCEO
sale4.00k-$248MS
Cluster Selling Direct Ownership Large Sale+1
—08/2708/26
MEDPTroendle August J.
PRESCEO
sale673-$41.7MS
Cluster Selling Direct Ownership Repeat Seller
—08/2708/25
MEDPTroendle August J.
PRESCEO
sale27.1k-$1.68BS
Cluster Selling Direct Ownership Large Sale+1
−3.2%08/2108/20
MEDPTroendle August J.
PRESCEO
sale15.6k-$946MS
Cluster Selling Direct Ownership Large Sale
−3.2%08/2108/19
MEDPTroendle August J.
CEO
exercise84.7k$0M
Derivative Transaction Direct Ownership
—03/10/202503/07/2025
MEDPTroendle August J.
CEO
exercise234k$0M
Derivative Transaction Direct Ownership
—03/10/202503/07/2025
MEDPTroendle August J.
CEO
exercise37.4k$0M
Derivative Transaction Direct Ownership
—03/10/202503/07/2025
MEDPTroendle August J.
CEO
grant73.4k$0A
Derivative Transaction Direct Ownership Large Holdings Increase
—03/10/202503/06/2025
MEDPTroendle August J.
CEO
exercise84.7k$914MM
Direct Ownership
—03/10/202503/07/2025

Troendle August J. Insider Activity FAQ

SEC Form 4 context

Who is Troendle August J.?

Troendle August J. is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001622058.

Which companies has Troendle August J. reported transactions for?

Medpace Holdings, Inc.

When was Troendle August J.'s latest insider buy?

No open-market insider purchase is available for this period.

When was Troendle August J.'s latest insider sale?

sale at Medpace Holdings, Inc. on Aug 27, 2026 valued at $403,176.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.